FDX1 and neoplasm: Notably, FDX1 knockdown failed to attenuate the synergistic inhibitory effect of DSF+Vem, while FDX1 overexpression did not enhance this combinatorial efficacy (Supplementary Fig. 4D–G), suggesting the existence of FDX1-independent pathways mediating DSF+Vem’s anti-tumor activity.